CCAP

Includes 945 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.11 to $11.35, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

1. Includes 2,088 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.3499, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 2,627 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 64 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,181 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securites Act of 1934.

The reporting person received 3,022 shares as part of a pro rata distribution from Crescent CCAP 10b5-1 Associates LLC (the "Distribution"). No consideration was paid in connection with the Distribution, which was exempt from Section 16 pursuant to Rule 16a-9.

Includes 291 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc., in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

The reporting person received 6,044 shares as part of a pro rata distribution from Crescent CCAP 10b5-1 Associates LLC (the "Distribution"). No consideration was paid in connection with the Distribution, which was exempt from Section 16 pursuant to Rule 16a-9.

The reporting person received 1,511 shares as part of a pro rata distribution from Crescent CCAP 10b5-1 Associates LLC (the "Distribution"). No consideration was paid in connection with the Distribution, which was exempt from Section 16 pursuant to Rule 16a-9.

Includes 2,503 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc., in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.14 to $17.2299, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

1. Includes 435 additional shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in April 2022 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.77 to $17.86, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.38 to $17.47, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote

Includes 408 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2022 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934

This transaction was executed in multiple trades at prices ranging from $18.14 to $18.31. The shares sold include 38,056 shares sold by Allied World and 14,619 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.04 to $18.14. The shares sold include 23,515 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 9,033 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both subsidiaries of Fairfax Financial Holdings Limited.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.08. The shares sold include 14,621 shares sold by Allied World and 5,617 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.15. The shares sold include 29,559 shares sold by Allied World and 11,355 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.06. The shares sold include 9,868 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 3,791 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both subsidiaries of Fairfax Financial Holdings Limited.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

The shares sold include 66,482 shares sold by Allied World and 25,538 shares sold by Brit. This transaction was executed in multiple trades at prices ranging from $18.00 to $18.14. The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

The shares sold include 14,301 shares sold by Allied World and 5,494 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which is also a wholly-owned subsidiary of Fairfax Financial Holdings Limited.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

The shares were sold by Allied World Assurance Company, Ltd., GmbH ("Allied World"), which is a wholly-owned subsidiary of Fairfax Financial Holdings Limited.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.10. The shares sold include 74,676 shares sold by Allied World and 28,609 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.06. The shares sold include 74,091 shares sold by Allied World and 28,385 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.03. The shares sold include 51,469 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 19,718 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both wholly-owned subsidiaries of Fairfax Financial Holdings Limited.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.29. The shares sold include 21,909 shares sold by Allied World and 8,394 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.17. The shares sold include 45,595 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 17,468 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both wholly-owned subsidiaries of Fairfax Financial Holdings Limited.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.38. The shares sold include 37,602 shares sold by Allied World and 14,405 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.00 to $18.17. The shares sold include 20,357 shares sold by Allied World and 7,799 shares sold by Brit.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.

This transaction was executed in multiple trades at prices ranging from $18.25 to $18.32. The shares sold include 4,895 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 1,875 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both wholly-owned subsidiaries of Fairfax Financial Holdings Limited.

The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.